Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3678077
Max Phase: Preclinical
Molecular Formula: C16H24F2N2O2
Molecular Weight: 314.38
Molecule Type: Small molecule
Associated Items:
ID: ALA3678077
Max Phase: Preclinical
Molecular Formula: C16H24F2N2O2
Molecular Weight: 314.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCOc1ccc(F)c(CCNCC(=O)N(C)C)c1F
Standard InChI: InChI=1S/C16H24F2N2O2/c1-4-5-10-22-14-7-6-13(17)12(16(14)18)8-9-19-11-15(21)20(2)3/h6-7,19H,4-5,8-11H2,1-3H3
Standard InChI Key: NUAHCZNEPOUXAO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 314.38 | Molecular Weight (Monoisotopic): 314.1806 | AlogP: 2.36 | #Rotatable Bonds: 9 |
Polar Surface Area: 41.57 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.23 | CX LogP: 2.39 | CX LogD: 1.50 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.71 | Np Likeness Score: -1.36 |
1. (2015) Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators, |
Source(1):